Drug Type Small molecule drug |
Synonyms HSD 016, HSD-016 |
Target |
Action inhibitors |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H21F7N2O3S |
InChIKeyZWASRJHIEFYJGL-BFUOFWGJSA-N |
CAS Registry946396-92-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | United States | 02 Aug 2011 |